RAC1 expression increases with the tumour progression, and hyperactivation and/or overexpression are associated with a very poor prognosis23, while, on the contrary, ZNF750 levels significantly decrease with the breast cancer stage and negatively correlate with cancer aggressiveness. This evidence concerns the gene RAC1 and breast carcinoma.